Golimumab-associated persistent erythema multiforme in a patient with ulcerative colitis in full remission
We report herein a 41-year-old woman with persistent erythema multiforme, that occurred 18 months after onset of golimumab treatment of her ulcerative colitis; the latter remains in full remission over a period of 36 months.
Source: Dermatology Online Journal - Category: Dermatology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Autoimmune Disease | Cancer & Oncology | Dermatology | Inflammatory Bowel Disease | Men | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Skin | Ulcerative Colitis | Vaccines